Publications by authors named "Inger Westborg"

Claim this Profile
F
Faricimab versus bevacizumab for neovascular age-related macular degeneration: Cost analysis based on real-world data from the Swedish Macula Registry.
Souad Abdalla, Inger Westborg, Anni-Maria Pulkki-Brännström, Helena Norberg

Acta Ophthalmol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study.
Inger Westborg, Ayat Al-Najjar, Helena Norberg

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register.
Monica Lövestam Adrian, Marion Schroeder, Inger Westborg

Acta Ophthalmol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden.
Marion Schroeder, Inger Westborg, Caroline Fluur, Rasmus Olsen, Monica Lövestam-Adrian

Acta Ophthalmol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of age-related macular degeneration after cataract surgery: a study from the Swedish National Cataract and Macula Registers.
Inger Westborg, Susanne Albrecht, Elisabet Granstam, Niklas Karlsson, Maria Kugelberg

Acta Ophthalmol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-Up After Cataract Surgery - Comparison of the Practice in Two Institutions with the Aim of Optimize the Routine.
Inger Westborg, Eva Mönestam

Clin Ophthalmol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR).
Marion Schroeder, Inger Westborg, Monica Lövestam Adrian

Acta Ophthalmol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register.
Monica Lövestam Adrian, Zdravko P Vassilev, Inger Westborg

Acta Ophthalmol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration.
Inger Westborg, Aldana Rosso

Ophthalmic Epidemiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for neovascular age-related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register.
Inger Westborg, Elisabet Granstam, Aldana Rosso, Susanne Albrecht, Niklas Karlsson

Acta Ophthalmol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Inger Westborg, Susanne Albrecht, Aldana Rosso

Retina· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing number of postoperative visits after cataract surgery: Safety perspective.
Inger Westborg, Eva Mönestam

J Cataract Refract Surg· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced occurrence of severe visual impairment after introduction of anti-Vascular Endothelial Growth Factor in wet age-related macular degeneration - a population- and register-based study from northern Sweden.
Elisabet Granstam, Inger Westborg, Anna Barkander, Malin Börjesson, Sara Lindahl

Acta Ophthalmol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.
Ian A Rodrigues, Sara M Sprinkhuizen, Daniel Barthelmes, Mark Blumenkranz, Gemmy Cheung, Inger Westborg

Am J Ophthalmol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracameral anesthesia for cataract surgery: a population-based study on patient satisfaction and outcome.
Inger Westborg, Eva Mönestam

Clin Ophthalmol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis